Blueweave
Global Neurodiagnostics Market

Global Neurodiagnostics Market

SPECIAL OFFER : 25% Super Discount For All !

Global Neurodiagnostics Market, By Product (Diagnostic Imaging Systems, Clinical Diagnostic Instruments, Reagents & Consumables), By Application (Neurodegenerative Diseases, Headache Disorders, Stroke, Sleep Disorders, Epilepsy), By End-User (Hospitals & Surgical Centers, Ambulatory Care Settings, Diagnostic Laboratories & Imaging Centers, Neurology Centers, Academic & Research Institutes), By Region (North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle-East & Africa (MEA) Trend Analysis, Competitive Market Share & Forecast, 2017-2027

  • Published Date: July 2021
  • Report ID: BWC2105
  • Available Format: PDF
  • Page: 200
  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Key Market Segments
  2. Research Methodology
    1. Qualitative Research
    2. Methodology
    3. Regional Split of Primary & Secondary Research
    4. Secondary Research
    5. Primary Research
      1. Breakdown of Primary Research Respondents, By Region
      2. Breakdown of Primary Research Respondents, By Industry Participants
    6. Market Size Estimation
    7. Assumptions for the Study
    8. Market Breakdown & Data Triangulation
  3. Executive Summary
  4. Industry Insight and Growth Strategy
    1. Value Chain Analysis
    2. DROC Analysis
      1. Market Drivers
        1. Increasing Prevalence of Neurodegenerative Diseases
        2. Technological Advancements in The Neurodiagnostics
        3. Neuroimaging Techniques
      2. Market Restraints
        1. High Cost of Diagnosis and Imaging Technologies
      3. Market Challenges
          1. Use of refurbished Products
      4. Market Opportunity
        1. The Ongoing Covid-19 Pandemic
        2. Increasing Research and Development Activities
    3. Recent Developments
    4. Porter’s Five Forces Analysis
      1. Bargaining Power of Buyers
      2. Bargaining Power of Suppliers
      3. Intensity of Rivalry
      4. Threat of New Entrants
      5. Threat of Substitutes
  5. Global Neurodiagnostics Market Overview
    1. Market Size & Forecast by Value, 2017-2027
    2. Market Size and Forecast, By Segment
      1. By Product
        1. Diagnostic Imaging Systems
          1. Ultrasound Imaging Systems
          2. EEG Systems
          3. MEG Devices
          4. MRI Systems
          5. Angiography Systems
          6. PET Scanners
          7. CT Scanners
          8. EMG Devices
          9. Other Diagnostic Imaging Systems
        2. Clinical Diagnostic Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Sanger Sequencers
          4. Other Clinical Diagnostic Instruments
        3. Reagents & Consumables
          1. Media & Sera
          2. Probes
          3. Antibodies
          4. Enzymes, Proteins, & Peptides
          5. Buffers
          6. Solvents
          7. Other Reagents & Consumables
      2. By Application
        1. Neurodegenerative Diseases
        2. Headache Disorders
        3. Stroke
        4. Sleep Disorders
        5. Epilepsy
      3. By End-user
        1. Hospitals & Surgical Centers
        2. Ambulatory Care Settings
        3. Diagnostic Laboratories & Imaging Centers
        4. Neurology Centers
        5. Academic & Research Institutes
      4. By Region
        1. North America
        2. Europe
        3. Asia-Pacific
        4. Latin America
        5. Middle East & Africa
  6. North America Neurodiagnostics Market Overview
    1. Market Size and Forecast
      1. By Value (USD Million), 2020-2027
    2. Market Share and Forecast
      1. By Product
      2. By Application
      3. By End User
      4. By Country
        1. U.S.
        2. Canada
  7. Europe Neurodiagnostics Market Overview
    1. Market Size and Forecast
      1. By Value (USD Million), 2020-2027
    2. Market Share and Forecast
      1. By Product
      2. By Application
      3. By End User
      4. By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
  8. APAC Neurodiagnostics Market Overview
    1. Market Size and Forecast
      1. By Value (USD Million), 2020-2027
    2. Market Share and Forecast
      1. By Product
      2. By Application
      3. By End User
      4. By Country
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Rest of APAC
  9. LATAM Neurodiagnostics Market Overview
    1. Market Size and Forecast
      1. By Value (USD Million), 2020-2027
    2. Market Share and Forecast
      1. By Product
      2. By Application
      3. By End User
      4. By Country
        1. Mexico
        2. Brazil
        3. Rest of LATAM
  10.  MEA Neurodiagnostics Market Overview
    1. Market Size and Forecast
      1. By Value (USD Million), 2020-2027
    2. Market Share and Forecast
    3. By Product
    4. By Application
    5. By End User
    6. By Country
      1. Saudi Arabia
      2. UAE
      3. South Africa
      4. Rest of Europe
  11. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Market Share Analysis (2020)
    3. Competitive Benchmarking, By Operating Parameters
  12. Impact of COVID-19 on Global Neurodiagnostics Market
  13. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
    1. Nihon Kohden Corporation
    2. GE Healthcare
    3. Canon Medical Systems Corporation
    4. Advanced Brain Monitoring, Inc
    5. FUJIFILM Holdings Corporation
    6. Siemens Healthineers
    7. Hoffman-La Roche AG
    8. Lifelines Neuro Company
    9. Bio-Rad Laboratories
    10. Koninklijke Philips N.V.
    11. QIAGEN N.V.
    12. Natus Medical Incorporated
    13. Fujirebio
    14. Thermo Fisher Scientific, Inc
    15. Agilent Technologies
    16. Hitachi, Ltd
    17. Ridge Diagnostics
    18. Bruker
    19. Other Prominent Players
  14. Key Strategic Recommendations

 

List of Figures

 

 

Fig 1: Global Neurodiagnostics Segmentation

 

Fig 2: Global Neurodiagnostics Market Value Chain Analysis,

 

Fig 3: Company Market Share Analysis, 2020

 

Fig 4: Global Neurodiagnostics Market Size, By Value (USD Million), 2020-2027

 

Fig 5: Global Neurodiagnostics Market Share (%), By Product, By Value, 2020-2027

 

Fig 6: Global Neurodiagnostics Market Share (%), By Application, By Value, 2020-2027

 

Fig 7: Global Neurodiagnostics Market Share (%), By End User, By Value, 2020-2027

 

Fig 8: Global Neurodiagnostics Market Share (%), By Country, By Value, 2020-2027

 

Fig 9: North America Neurodiagnostics Market Size, By Value (USD Million), 2020-2027

 

Fig 10: North America Neurodiagnostics Market Share (%), By Product, By Value, 2020-2027

 

Fig 11: North America Neurodiagnostics Market Share (%), By Application, By Value, 2020-2027

 

Fig 12: North America Neurodiagnostics Market Share (%), By End User, By Value, 2020-2027

 

Fig 13: North America Neurodiagnostics Market Share (%), By Country, By Value, 2020-2027

 

Fig 14: Europe Neurodiagnostics Market Size, By Value (USD Million), 2020-2027

 

Fig 15: Europe Neurodiagnostics Market Share (%), By Product, By Value, 2020-2027

 

Fig 16: Europe Neurodiagnostics Market Share (%), By Application, By Value, 2020-2027

 

Fig 17: Europe Neurodiagnostics Market Share (%), By End User, By Value, 2020-2027

 

Fig 18: Europe Neurodiagnostics Market Share (%), By Country, By Value, 2020-2027

 

Fig 19: the Asia-Pacific Neurodiagnostics Market Size, By Value (USD Million), 2020-2027

 

Fig 20: the Asia-Pacific Neurodiagnostics Market Share (%), By Product, By Value, 2020-2027

 

Fig 21: the Asia-Pacific Neurodiagnostics Market Share (%), By Application, By Value, 2020-2027

 

Fig 22: the Asia-Pacific Neurodiagnostics Market Share (%), By End User, By Value, 2020-2027

 

Fig 23: the Asia-Pacific Neurodiagnostics Market Share (%), By Country, By Value, 2020-2027

 

Fig 24: Latin America Neurodiagnostics Market Size, By Value (USD Million), 2020-2027

 

Fig 25: Latin America Neurodiagnostics Market Share (%), By Product, By Value, 2020-2027

 

Fig 26: Latin America Neurodiagnostics Market Share (%), By Application, By Value, 2020-2027

 

Fig 27: Latin America Neurodiagnostics Market Share (%), By End User, By Value, 2020-2027

 

Fig 28: Latin America Neurodiagnostics Market Share (%), By Country, By Value, 2020-2027

 

Fig 29: Middle East & Africa Neurodiagnostics Market Size, By Value (USD Million), 2020-2027

 

Fig 30: Middle East & Africa Neurodiagnostics Market Share (%), By Product, By Value, 2020-2027

 

Fig 31: Middle East & Africa Neurodiagnostics Market Share (%), By Application, By Value, 2020-2027

 

Fig 32: Middle East & Africa Neurodiagnostics Market Share (%), By End User, By Value, 2020-2027

 

Fig 33: Middle East & Africa Neurodiagnostics Market Share (%), By Region, By Value, 2020-2027

 

 

List of Tables

 

 

Table 1: Global Neurodiagnostics Market Size, By Product, By Value, 2020-2027

 

Table 2: Global Neurodiagnostics Market Size, By Application, By Value (USD Million), 2020-2027

 

Table 3: Global Neurodiagnostics Market Size, By End User, By Value (USD Million), 2020-2027

 

Table 4: Global Neurodiagnostics Market Size, By Region, By Value (USD Million), 2020-2027

 

Table 5: North America Neurodiagnostics Market Size, By Product, By Value (USD Million), 2020-2027

 

Table 6: North America Neurodiagnostics Market Size, By Application, By Value (USD Million), 2020-2027

 

Table6: North America Neurodiagnostics Market Size, By End User, By Value (USD Million), 2020-2027

 

Table7: North America Neurodiagnostics Market Size, By Country, By Value (USD Million), 2020-2027

 

Table8: Europe Neurodiagnostics Market Size, By Product, By Value (USD Million), 2020-2027

 

Table9: Europe Neurodiagnostics Market Size, By Application, By Value (USD Million), 2020-2027

 

Table 10: Europe Neurodiagnostics Market Size, By End User, By Value (USD Million), 2020-2027

 

Table 11: Europe Neurodiagnostics Market Size, By Country, By Value (USD Million), 2020-2027

 

Table 12: the Asia-Pacific Neurodiagnostics Market Size, By Product, By Value (USD Million), 2020-2027

 

Table 13: the Asia-Pacific Neurodiagnostics Market Size, By Application, By Value (USD Million), 2020-2027

 

Table 14: the Asia-Pacific Neurodiagnostics Market Size, By End User, By Value (USD Million), 2020-2027

 

Table 15: the Asia-Pacific Neurodiagnostics Market Size, By Country, By Value (USD Million), 2020-2027

 

Table 16: Latin America Neurodiagnostics Market Size, By Product, By Value (USD Million), 2020-2027

 

Table 17: Latin America Neurodiagnostics Market Size, By Application, By Value (USD Million), 2020-2027

 

Table 18: Latin America Neurodiagnostics Market Size, By End User, By Value (USD Million), 2020-2027

 

Table 19: Latin America Neurodiagnostics Market Size, By Country, By Value (USD Million), 2020-2027

 

Table 20: The Middle-East & Africa Neurodiagnostics Market Size, By Product, By Value (USD Million), 2020-2027

 

Table 21: The Middle-East & Africa Neurodiagnostics Market Size, By Application, By Value (USD Million), 2020-2027

 

Table 22: The Middle-East & Africa Neurodiagnostics Market Size, By End User, By Value (USD Million), 2020-2027

 

Table 23: The Middle-East & Africa Neurodiagnostics Market Size, By Country, By Value (USD Million), 2020-2027

 

Table 24: Nihon Kohden Corporation Financial Analysis

 

Table 25: Nihon Kohden Corporation Business Overview

Table 26: GE Healthcare Financial Analysis

Table 27: GE HealthcareBusiness Overview

Table 28: Canon Medical Systems Corporation Financial Analysis

Table 29: Canon Medical Systems Corporation Business Overview

Table 30: Advanced Brain Monitoring, IncFinancial Analysis

Table 31: Advanced Brain Monitoring, IncBusiness Overview

Table 32: FUJIFILM Holdings CorporationFinancial Analysis

Table 33: FUJIFILM Holdings CorporationBusiness Overview

Table 34: Siemens Healthineers Financial Analysis

Table 35: Siemens Healthineers Business Overview

Table 36: Hoffman-La Roche AG Financial Analysis

Table 37: Hoffman-La Roche AG Business Overview

Table 38: Lifelines Neuro Company Financial Analysis

Table 39: Lifelines Neuro Company Corporation Business Overview

Table 40: Bio-Rad LaboratoriesFinancial Analysis

Table 41: Bio-Rad LaboratoriesBusiness Overview

Table 42: Koninklijke Philips N.V. Financial Analysis

Table 43: Koninklijke Philips N.V. Business Overview

Table 44: QIAGEN N.V. MedicalFinancial Analysis

Table 45: QIAGEN N.V. Medical Financial Analysis

Table 46: Natus Medical Incorporated Financial Analysis

Table 47: Natus Medical Incorporated Business Overview

Table 48: Fujirebio Financial Analysis

Table 49:FujirebioBusiness Overview

Table 50: Thermo Fisher Scientific, Inc Financial Analysis

Table 51: Thermo Fisher Scientific, Inc Business Overview

Table 52: Agilent Technologies Financial Analysis

Table 53: Agilent Technologies Business Overview

Table 54: Hitachi, LtdFinancial Analysis

Table 55: Hitachi, Ltd Business Overview

Table 56: Ridge Diagnostics Financial Analysis

Table 57: Ridge Diagnostics Business Overview

Table 58: BrukerFinancial Analysis

Table 59: Bruker Business Overview